volume 107 issue 3 pages 347-359

The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor

Publication typeJournal Article
Publication date2001-11-01
scimago Q1
wos Q1
SJR22.612
CiteScore74.8
Impact factor42.5
ISSN00928674, 10974172
General Biochemistry, Genetics and Molecular Biology
Abstract
Telomerase activity is critical for normal and transformed human cells to escape from crisis and is implicated in oncogenesis. Here we describe a novel Pin2/TRF1 binding protein, PinX1 that inhibits telomerase activity and affects tumorigenicity. PinX1 and its small TID domain bind the telomerase catalytic subunit hTERT and potently inhibit its activity. Overexpression of PinX1 or its TID domain inhibits telomerase activity, shortens telomeres, and induces crisis, whereas depletion of endogenous PinX1 increases telomerase activity and elongates telomeres. Depletion of PinX1 also increases tumorigenicity in nude mice, consistent with its chromosome localization at 8p23, a region with frequent loss of heterozygosity in a number of human cancers. Thus, PinX1 is a potent telomerase inhibitor and a putative tumor suppressor.
Found 
Found 

Top-30

Journals

5
10
15
20
25
Journal of Biological Chemistry
22 publications, 8.87%
Biochemical and Biophysical Research Communications
9 publications, 3.63%
Molecular and Cellular Biology
8 publications, 3.23%
Cancer Letters
5 publications, 2.02%
Oncotarget
5 publications, 2.02%
Nucleic Acids Research
5 publications, 2.02%
Journal of Cell Science
3 publications, 1.21%
Experimental Cell Research
3 publications, 1.21%
Oncology Reports
3 publications, 1.21%
International Journal of Molecular Sciences
3 publications, 1.21%
Gene
3 publications, 1.21%
FEBS Letters
3 publications, 1.21%
International Journal of Cancer
3 publications, 1.21%
Molecular Biology and Evolution
3 publications, 1.21%
Frontiers in Bioscience - Landmark
3 publications, 1.21%
Mechanisms of Ageing and Development
2 publications, 0.81%
World Journal of Gastroenterology
2 publications, 0.81%
Cells
2 publications, 0.81%
Nature Cell Biology
2 publications, 0.81%
Journal of Cancer Research and Clinical Oncology
2 publications, 0.81%
Scientific Reports
2 publications, 0.81%
Oncogene
2 publications, 0.81%
Molecular Cancer
2 publications, 0.81%
Leukemia
2 publications, 0.81%
Nature Reviews Molecular Cell Biology
2 publications, 0.81%
PLoS ONE
2 publications, 0.81%
Critical Reviews in Oncology/Hematology
2 publications, 0.81%
Prostate
2 publications, 0.81%
Journal of Pathology
2 publications, 0.81%
5
10
15
20
25

Publishers

5
10
15
20
25
30
35
40
45
50
Elsevier
48 publications, 19.35%
Springer Nature
48 publications, 19.35%
Wiley
24 publications, 9.68%
American Society for Biochemistry and Molecular Biology
22 publications, 8.87%
American Society for Microbiology
11 publications, 4.44%
Oxford University Press
10 publications, 4.03%
Cold Spring Harbor Laboratory
10 publications, 4.03%
MDPI
9 publications, 3.63%
Spandidos Publications
8 publications, 3.23%
Impact Journals
5 publications, 2.02%
Taylor & Francis
5 publications, 2.02%
IMR Press
4 publications, 1.61%
The Company of Biologists
3 publications, 1.21%
Frontiers Media S.A.
3 publications, 1.21%
Public Library of Science (PLoS)
3 publications, 1.21%
American Association for the Advancement of Science (AAAS)
3 publications, 1.21%
Bentham Science Publishers Ltd.
2 publications, 0.81%
Baishideng Publishing Group
2 publications, 0.81%
Hindawi Limited
2 publications, 0.81%
Annual Reviews
2 publications, 0.81%
Pleiades Publishing
1 publication, 0.4%
The American Association of Immunologists
1 publication, 0.4%
American Society for Clinical Investigation
1 publication, 0.4%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.4%
Canadian Science Publishing
1 publication, 0.4%
Mary Ann Liebert
1 publication, 0.4%
Portland Press
1 publication, 0.4%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.4%
BMJ
1 publication, 0.4%
5
10
15
20
25
30
35
40
45
50
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
248
Share
Cite this
GOST |
Cite this
GOST Copy
Zhou X. Z., Lu K. The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor // Cell. 2001. Vol. 107. No. 3. pp. 347-359.
GOST all authors (up to 50) Copy
Zhou X. Z., Lu K. The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor // Cell. 2001. Vol. 107. No. 3. pp. 347-359.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0092-8674(01)00538-4
UR - https://doi.org/10.1016/S0092-8674(01)00538-4
TI - The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor
T2 - Cell
AU - Zhou, Xiao Zhen
AU - Lu, Kun
PY - 2001
DA - 2001/11/01
PB - Elsevier
SP - 347-359
IS - 3
VL - 107
PMID - 11701125
SN - 0092-8674
SN - 1097-4172
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2001_Zhou,
author = {Xiao Zhen Zhou and Kun Lu},
title = {The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor},
journal = {Cell},
year = {2001},
volume = {107},
publisher = {Elsevier},
month = {nov},
url = {https://doi.org/10.1016/S0092-8674(01)00538-4},
number = {3},
pages = {347--359},
doi = {10.1016/S0092-8674(01)00538-4}
}
MLA
Cite this
MLA Copy
Zhou, Xiao Zhen, and Kun Lu. “The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor.” Cell, vol. 107, no. 3, Nov. 2001, pp. 347-359. https://doi.org/10.1016/S0092-8674(01)00538-4.